About Nuclear receptor ROR-beta
Nuclear receptor ROR-beta (RORB) is a protein
from Homo sapiens identified by UniProt accession
Q92753, 470 residues long.
MolForge cross-references it against 0 known binders and
234 disease associations.
Target properties
| Protein name | Nuclear receptor ROR-beta |
| UniProt accession | Q92753 |
| Gene | RORB |
| Organism | Homo sapiens |
| Length | 470 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (1)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (234)
Diseases linked to this target (Open Targets).
- generalised epilepsy · score 0.73
- neurodegenerative disease · score 0.55
- genetic disorder · score 0.49
- testosterone measurement · score 0.47
- body height · score 0.43
- reticulocyte count · score 0.43
- age at menarche · score 0.42
- refractive error measurement · score 0.42
- Abnormality of refraction · score 0.41
- refractive error · score 0.41
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q92753-F1 | alphafold | PREDICTED | 78.80 | — |
Amino-acid sequence (470 residues)
MCENQLKTKA DATAQIEVIP CKICGDKSSG IHYGVITCEG CKGFFRRSQQ NNASYSCPRQ RNCLIDRTNR NRCQHCRLQK CLALGMSRDA VKFGRMSKKQ RDSLYAEVQK HQQRLQEQRQ QQSGEAEALA RVYSSSISNG LSNLNNETSG TYANGHVIDL PKSEGYYNVD SGQPSPDQSG LDMTGIKQIK QEPIYDLTSV PNLFTYSSFN NGQLAPGITM TEIDRIAQNI IKSHLETCQY TMEELHQLAW QTHTYEEIKA YQSKSREALW QQCAIQITHA IQYVVEFAKR ITGFMELCQN DQILLLKSGC LEVVLVRMCR AFNPLNNTVL FEGKYGGMQM FKALGSDDLV NEAFDFAKNL CSLQLTEEEI ALFSSAVLIS PDRAWLIEPR KVQKLQEKIY FALQHVIQKN HLDDETLAKL IAKIPTITAV CNLHGEKLQV FKQSHPEIVN TLFPPLYKEL FNPDCATGCK
Explore Nuclear receptor ROR-beta with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets